Journal of Pierre Fauchard Academy (India Section)

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Evaluation of Clinical Effectiveness of Bioactive - Glass and Platelet - Rich Fibrin in the Management of Intrabony Defects - A Comparative Study


Affiliations
1 SRM Kattankulathur Dental College & Hospital, Chennai, India
2 Tamil Nadu Government Dental College & Hospital, Chennai, India
3 Post Graduate Student, Tamil Nadu Government Dental College & Hospital, Chennai, India
     

   Subscribe/Renew Journal


Background: Platelet-Rich Fibrin (PRF), the second-generation platelet concentrate has various fringe benefits over other platelet concentrates. Just finite number of research works have concentrated on the utilization of PRF in combination with various kinds of bone grafts in intra-bony defects. Objective: The primary intention of this study was to determine the clinical and radiographical efficacy of Bioactive-glass with and without autologous PRF in the management of three-wall vertical defects. Methods: Twenty intrabony defects were arbitrarily chosen and treated either with Bioactive Glass (BG) alone or in mix with PRF (PRF/BG). Clinical parameters were documented preoperatively (baseline) and at six months post-operatively. Radiographic analysis was performed at baseline, third and sixth-month intervals. Results: The study outcome demonstrated that both treatment approaches were effectual. Significant decrease in the mean probing depth and gain in clinical attachment was observed in BG+PRF and BG groups as compared to baseline but was statistically insignificant at 6 months. (p=0.475, p=0.245 respectively). Radiographically, reduction in defect depth was significantly greater in BG+PRF group than BG group (p=0.007) at 6 months. Conclusion: Within the limitation of the current study, it is proposed that both treatment modalities are effective in the management of 3-wall intra-bony defects. The outcomes additionally uncovered that incorporation of PRF with BG has more successful and promising results. Hence in future, clinical trials with bigger sample size may be employed to further explore the potential benefits of PRF as a sole grafting material.

Keywords

Blood Platelets, Glass, Intrabony, Regeneration.
User
Subscription Login to verify subscription
Notifications
Font Size

  • Giannobile WV. The potential role of growth and differentiation factors in periodontal regeneration. J Periodontol. 1996;67(5):545–553.

  • Schepers EJ, Ducheyne P. Bioactive glass particles of narrow size range for the treatment of oral bone defects: a 1-24 month experiment with several materials and particle sizes and size ranges. J Oral Rehabil. 1997;24(3):171–181. https://doi.org/10.1111/j.1365-2842.1997.tb00311.x

  • Osteostimulation of bioglass.Hu YC, Zhong JP. Osteostimulation of bioglass. Chin Med J (Engl). 2009 Oct 5;122(19): 2386–1289.

  • Chen FM, Shelton RM, Jin Y, Chapple IL. Localized delivery of growth factors for periodontal tissue regeneration: role, strategies, and perspectives. Med res Rev. 2009;29(3):472– 513. https://doi.org/10.1002/med.20144. PMid:19260070

  • Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. PlateletRich Fibrin (PRF): a secondgeneration platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3): e37–e44. https://doi.org/10.1016/j.tripleo.2005.07.008

  • Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002;70(12):6524–6533. https://doi.org/10.1128/IAI.70.12.6524-6533. 2002. PMid:12438321 PMCid:PMC132966

  • Lekovic V, Milinkovic I, Aleksic Z, Jankovic S, Stankovic P, Kenney EB, et al. Platelet-rich fibrin and bovine porous bone mineral vs. platelet-rich fibrin in the treatment of intrabony periodontal defects. J Periodontal Res. 2012;47(4):409–417. https://doi.org/10.1111/j.1600-0765.2011.01446.x. PMid:22126591

  • Pradeep AR, Bajaj P, Rao NS, Aggarwal E, Naik SB. Platelet rich fibrin combined with a porous hydroxyapatite graft for the treatment of three-wall intrabony defects in chronic periodontitis: A randomized controlled clinical trial. J Periodontol. 2017;88(12):1288–1296. https://doi.org/10.1902/jop.2012.110722

  • Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999 Dec;4(1):1–6.

  • Björn H, Halling A, Thyberg H. Radiographic assessment of marginal bone loss. Odontol Revy.1969;20(2):165–179. PMid:5259016

  • Schei O, Waerhaug J, Lovdal A, Arno A. Alveolar bone loss as related to oral hygiene and age. J Periodontol.1959;30:7–16. https://doi.org/10.1902/jop.1959.30.1.7

  • Li-ares A, Cortellini P, Lang NP, Suvan J, Tonetti MS. European research group on periodontology (ErgoPerio). Guided tissue regeneration/ deproteinized bovine bone mineral or papilla preservation flaps alone for treatment of intrabony defects. II: radiographic predictors and outcomes. J Clin Periodontol. 2006;33(5): 351-8. https://doi.org/10.1111/j.1600-051X.2006.00911.x. PMid:16634957

  • Prapayasatok S, Janhom A, Verochana K, Pramojanee S. Digital camera resolution and proximal caries detection. Dentomaxillofac Radiol. 2006;35(4):253–77. https://doi.org/10.1259/dmfr/32165678. PMid:16798921

  • Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin -1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve all surgical platelet concentrates technologies. Growth Factors. 2009;27(1):63–69. https://doi.org/10.1080/08977190802636713. PMid:19089687

  • Thorat M, Pradeep AR, Pallavi B. Clinical effect of autologous platelet-rich fibrin in the treatment of intra-bony defects: a controlled clinical trial. J Clin Periodontol. 2011;38(10):925–932. https://doi.org/10.1111/j.1600051X.2011.01760.x. PMid:21777267

  • Trombelli L, Heitz-Mayfield LJ, Needleman I, Moles D, Scabbia A. A systematic review of graft materials and biological agents for periodontal intraosseous defects. J Clin Periodontol. 2002;29 Suppl 3:117–135. https://doi.org/10.1034/j.1600-051X.29.s3.7.x. PMid:12787213

  • Allan I, Newman H, Wilson M. Antibacterial activity of particulate bioglass against supra- and subgingival bacteria. Biomaterials. 2001;22(12):1683–1687. https://doi.org/10.1016/S0142-9612(00)00330-6

  • Low SB, King CJ, Krieger J. An evaluation of bioactive ceramic in the treatment of periodontal osseous defects. Int J Periodontics Restorative Dent. 1997;17(4):358–367. PMid:9497726

  • Zamet JS, Darbar UR, Griffiths GS, Bulman JS, Brägger U, Bürgin W, et al. Particulate bioglass as a grafting material in the treatment of periodontal intrabony defects. J Clin Periodontol. 1997;24(6):410–418. https://doi.org/10.1111/ j.1600-051X.1997.tb00205.x

  • Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(6):638–646. https://doi. org/10.1016/S1079-2104(98)90029-4

  • Okuda K, Tai H, Tanabe K, Suzuki H, Sato T, Kawase T, et al. Platelet-rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans: a comparative controlled clinical study. J Periodontol. 2005;76:890–898. https://doi.org/10.1902/ jop.2005.76.6.890. PMid:15948682

  • Demir B, Sengün D, Berberoğlu A. Clinical evaluation of platelet-rich plasma and bioactive glass in the treatment of intra-bony defects. J Clin Periodontol. 2007;34(8):709–715.

  • https://doi.org/10.1111/j.1600-051X.2007.01108.x. PMid:17635247

  • Clark RA. Fibrin and wound healing. Ann N Y Acad Sci. 2001;936:355–367. https://doi.org/10.1111/j.1749-6632.2001.tb03522.x. PMid:11460492

  • Choukroun J, Adda F, Schoeffler C, Vervelle A. Une opportunité en paro-implantologie: Le PRF. Implantodontie. 2001;42:55–62.

  • Nevins ML, Camelo M, Nevins M, King CJ, Oringer RJ, Schenk RK, et al. Human histologic evaluation of bioactive ceramic in the treatment of periodontal osseous defects. Int J Periodontics Restorative Dent. 2000;20(5):459–467.

  • Prichard JF. The intrabony technique as a predictable procedure. J Periodontol. 1957;28:202–216. https://doi.org/10.1902/jop.1957.28.3.202

  • Blumenthal NM, Alves ME, Al-Huwais S, Hofbauer AM, Koperski RD. Defect-determined regenerative options for treating periodontal intrabony defects in baboons. J Periodontol. 2003;74(1):10–24. https://doi.org/10.1902/ jop.2003.74.1.10. PMid:12593591

  • Yukna RA, Krauser JT, Evans GH, Cruz R, Martin M. Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defect. 6 months results. J Periodontol. 2000;71(11): 1671–179. https://doi.org/10.1902/jop.2000.71.11.1671. PMid:11128913

  • Rosen PS, Reynolds MA, Bowers GM. The treatment of intrabony defects with bone grafts. Periodontol 2000. 2000;22:88–103. https://doi.org/10.1034/j.16000757.2000.2220107.x. PMid:11276519


Abstract Views: 194

PDF Views: 0




  • Evaluation of Clinical Effectiveness of Bioactive - Glass and Platelet - Rich Fibrin in the Management of Intrabony Defects - A Comparative Study

Abstract Views: 194  |  PDF Views: 0

Authors

M. Prem Blaisie Rajula
SRM Kattankulathur Dental College & Hospital, Chennai, India
Malathi Subramanioum
Tamil Nadu Government Dental College & Hospital, Chennai, India
Muthukumaraswamy
Tamil Nadu Government Dental College & Hospital, Chennai, India
Arjun Singh
Post Graduate Student, Tamil Nadu Government Dental College & Hospital, Chennai, India

Abstract


Background: Platelet-Rich Fibrin (PRF), the second-generation platelet concentrate has various fringe benefits over other platelet concentrates. Just finite number of research works have concentrated on the utilization of PRF in combination with various kinds of bone grafts in intra-bony defects. Objective: The primary intention of this study was to determine the clinical and radiographical efficacy of Bioactive-glass with and without autologous PRF in the management of three-wall vertical defects. Methods: Twenty intrabony defects were arbitrarily chosen and treated either with Bioactive Glass (BG) alone or in mix with PRF (PRF/BG). Clinical parameters were documented preoperatively (baseline) and at six months post-operatively. Radiographic analysis was performed at baseline, third and sixth-month intervals. Results: The study outcome demonstrated that both treatment approaches were effectual. Significant decrease in the mean probing depth and gain in clinical attachment was observed in BG+PRF and BG groups as compared to baseline but was statistically insignificant at 6 months. (p=0.475, p=0.245 respectively). Radiographically, reduction in defect depth was significantly greater in BG+PRF group than BG group (p=0.007) at 6 months. Conclusion: Within the limitation of the current study, it is proposed that both treatment modalities are effective in the management of 3-wall intra-bony defects. The outcomes additionally uncovered that incorporation of PRF with BG has more successful and promising results. Hence in future, clinical trials with bigger sample size may be employed to further explore the potential benefits of PRF as a sole grafting material.

Keywords


Blood Platelets, Glass, Intrabony, Regeneration.

References





DOI: https://doi.org/10.18311/jpfa%2F2018%2F22130